Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 183   

Articles published

GSK 1,553.50 -10.00 (-0.64%)
price chart
You Can't Go Far Wrong Buying GlaxoSmithKline plc At Today's Price
It has been some time since pharmaceutical giant GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has been this cheap.
Is There Still Time To Buy GlaxoSmithKline plc?
Right now I'm looking at some of the most popular companies in the FTSE 100 and wider market to try and establish if there is still time for investors to buy in.
Glaxo: Results for heart-disease drug disappoint  MarketWatch
Glaxo Withdraws Application For Ovarian Cancer Treatment  Wall Street Journal
Related articles »  
3 Reasons Why GlaxoSmithKline plc Is More Than Just A Great Income Stock
With interest rates remaining at historic lows (and looking as though they could remain there for a while), stocks with relatively high yields have become increasingly popular.
GlaxoSmithKline discloses new bribery inquiries  Belleville News Democrat
Related articles »  
Should You Buy GlaxoSmithKline plc After Recent Declines?
I've been waiting for a good opportunity to buy into GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) for some time now. Luckily, recent declines have made Glaxo's shares look attractive on a valuation basis but there are some issues surrounding the company ...
GlaxoSmithKline plc Stumbles But It's Still A Buy
Drug-maker GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has announced its third setback in almost as many days with news of failed drugs trials.
GlaxoSmithKline throws in towel on lung cancer vaccine trial  Reuters
Related articles »  
Buy Stocks Like Diageo plc And GlaxoSmithKline plc To Hedge Against Labour ...
The General election is just over 12 months away, and the latest YouGov poll shows Labour with a 7% lead over the Tories. It could be time for investors to position their portfolios in anticipation of a potential Labour victory.
GlaxoSmithKline plc Tops The Pharmaceuticals sector
I mean no disrespect to Shire, but its market capitalisation of a relatively low �17.1bn compared to �48.8bn for AstraZeneca and �75.5bn for GlaxoSmithKline means it really doesn't have the clout to be a top-of-the-sector candidate. But between the two ...
Is GlaxoSmithKline plc Just A Tracker Fund In Disguise?
I hold Glaxo, and I hold a tracker fund, the HSBC FTSE 100 Index. Both have served me well. But why hold both? After all, 4.4% of my tracker fund is actually made up of Glaxo, with its massive �80 billion market cap. The tracker gives me a dab of ...
Related articles »  
(Video) GlaxoSmithKline plc's Bribery Allegations
(Video) GlaxoSmithKline plc's Bribery Allegations. By Owain Bennallack - Wednesday, 16 April, 2014 | See also: GSKGSK. Tweet.
Related articles »  
GlaxoSmithKline plc (ADR) (NYSE:GSK): A Drug To Tackle Bribery Scandals
Tomahawk, WI 04/15/2014 (Basicsmedia) - It's not like GlaxoSmithKline plc (ADR) (NYSE:GSK) is the only drug maker that has the tendency to get ensnared in corruption and bribery scandals.